CSPC Pharmaceutical Group Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CSPC Pharmaceutical Group Ltd with three other
companies in this sector in the United States:
United Therapeutics Corporation
sales of $1.47 billion
of which 100%
of which 62%
was Oral Technologies), and
of which 64%
CSPC Pharmaceutical Group Ltd reported sales of $1.47 billion
December of 2015.
increase of 4.1%
versus 2014, when the company's sales were $1.41 billion.
This was the third consecutive year of growth at CSPC Pharmaceutical Group Ltd.
Sales of Finished Drugs saw an increase
that was more than double the company's growth rate: sales were up
16.1% in 2015, from
$865.98 million to $1.01 billion.
CSPC Pharmaceutical Group Ltd also saw significant increases in sales in
Caffeine and Other (up 8.6% to $87.58 million)
Not all segments of CSPC Pharmaceutical Group Ltd experienced an increase in sales in 2015:
sales of Antibiotics Series fell 27.5% to $221.68 million.
CSPC Pharmaceutical Group Ltd also experienced decreases in sales in
Vitamin C Series (down 3.2% to $155.15 million)